Screener
Trevi Therapeutics, Inc. TRVI Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The source filing: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206390
| Line item | Common Stock / Shares | Common Stock / Amount | Additional / Paid- / in Capital | Accumulated Other / Comprehensive / (Loss) Income | Accumulated / Deficit | Total / Stockholders’ / Equity |
|---|---|---|---|---|---|---|
| Balance at December 31, 2025 | 128,306,056 | $128 | $512,772 | $148 | $(329,804) | $183,244 |
| Stock-based compensation | — | — | 2,191 | — | — | 2,191 |
| Issuance of common stock from exercise of stock options | 104,992 | — | 222 | — | — | 222 |
| Unrealized losses on available-for-sale marketable securities | — | — | — | (338) | — | (338) |
| Net loss | — | — | — | — | (13,192) | (13,192) |
| Balance at March 31, 2026 | 128,411,048 | $128 | $515,185 | $(190) | $(342,996) | $172,127 |
| Balance at December 31, 2024 | 93,602,631 | $94 | $386,534 | $61 | $(287,045) | $99,644 |
| Stock-based compensation | — | — | 1,208 | — | — | 1,208 |
Item 1. Condensed Consolidated Financial Statements.
FAQ
- What is Trevi Therapeutics, Inc.'s stock issued during period, value, stock options exercised?
- Trevi Therapeutics, Inc. (TRVI) reported stock issued during period, value, stock options exercised of $222K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s stock issued during period, value, stock options exercised changed year-over-year?
- Trevi Therapeutics, Inc.'s stock issued during period, value, stock options exercised decreased by 69.1% year-over-year, from $718K to $222K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s stock issued during period, value, stock options exercised?
- Over 2 years (2023 to 2025), Trevi Therapeutics, Inc.'s stock issued during period, value, stock options exercised has grown at a 433.7% compound annual growth rate (CAGR), from $73K to $2.08M.
- What does stock issued during period, value, stock options exercised mean?
- The total dollar value of common stock issued resulting from the exercise of employee or director stock options. This reflects the cash inflow from equity-based compensation programs and the dilution impact on existing shareholders. It serves as an indicator of employee participation in equity incentive plans.
Ask your AI about Trevi Therapeutics, Inc.'s stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude